These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15906570)
1. Behavioral responses to two intranasal vaccine applicators in horses and ponies. Grogan EH; McDonnell SM J Am Vet Med Assoc; 2005 May; 226(10):1689-93. PubMed ID: 15906570 [TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. Lunn DP; Hussey S; Sebing R; Rushlow KE; Radecki SV; Whitaker-Dowling P; Youngner JS; Chambers TM; Holland RE; Horohov DW J Am Vet Med Assoc; 2001 Mar; 218(6):900-6. PubMed ID: 11294315 [TBL] [Abstract][Full Text] [Related]
3. [The use of a GnRH vaccine in mares and stallions to influence undesirable behavior: a retrospective study of 31 cases]. Wenzinger B; Kähn W; Bleul U Schweiz Arch Tierheilkd; 2010 Aug; 152(8):373-7. PubMed ID: 20683826 [TBL] [Abstract][Full Text] [Related]
4. Effects of GnRH immunization in sexually mature pony stallions. Turkstra JA; van der Meer FJ; Knaap J; Rottier PJ; Teerds KJ; Colenbrander B; Meloen RH Anim Reprod Sci; 2005 Apr; 86(3-4):247-59. PubMed ID: 15766804 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a commercially available modified-live Streptococcus equi subsp equi vaccine in ponies. Borst LB; Patterson SK; Lanka S; Barger AM; Fredrickson RL; Maddox CW Am J Vet Res; 2011 Aug; 72(8):1130-8. PubMed ID: 21801073 [TBL] [Abstract][Full Text] [Related]
6. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Chambers TM; Holland RE; Tudor LR; Townsend HG; Cook A; Bogdan J; Lunn DP; Hussey S; Whitaker-Dowling P; Youngner JS; Sebring RW; Penner SJ; Stiegler GL Equine Vet J; 2001 Nov; 33(7):630-6. PubMed ID: 11770982 [TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical differences in adenohypophyseal cells among adult Mongolian pony mares, stallions, and geldings. Tan JH; Nanbo Y; Oikawa M; Kiso Y; Sasaki F Am J Vet Res; 1998 Mar; 59(3):262-6. PubMed ID: 9522941 [TBL] [Abstract][Full Text] [Related]
8. Misbehaviour in Pony Club horses: incidence and risk factors. Buckley P; Morton JM; Buckley DJ; Coleman GT Equine Vet J; 2013 Jan; 45(1):9-14. PubMed ID: 23237295 [TBL] [Abstract][Full Text] [Related]
9. Intranasal immunogenicity of a Delta cya Delta crp-pabA mutant of Salmonella enterica serotype Typhimurium for the horse. Sheoran AS; Timoney JF; Tinge SA; Sundaram P; Curtiss R Vaccine; 2001 Jun; 19(27):3787-95. PubMed ID: 11395214 [TBL] [Abstract][Full Text] [Related]
10. Social relationships in a herd of 11 geldings and two female ponies. Wood-Gush DG; Galbraith F Equine Vet J; 1987 Mar; 19(2):129-32. PubMed ID: 3569194 [TBL] [Abstract][Full Text] [Related]
11. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Soboll G; Nelson KM; Leuthner ES; Clark RJ; Drape R; Macklin MD; Swain WF; Olsen CW; Lunn DP Vaccine; 2003 Jun; 21(21-22):3081-92. PubMed ID: 12798652 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine. Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146 [TBL] [Abstract][Full Text] [Related]
13. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza. Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250 [TBL] [Abstract][Full Text] [Related]
14. [Prevalence of dental disorders in 483 horses and ponies]. Peters JW; de Boer B; Broeze-ten Voorde G; Broeze J; Wiemer P; Sterk T; Spoormakers T Tijdschr Diergeneeskd; 2008 Apr; 133(7):272-8. PubMed ID: 18447114 [TBL] [Abstract][Full Text] [Related]
15. Needle size for vaccination procedures in children and adolescents. Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647 [TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586 [TBL] [Abstract][Full Text] [Related]
17. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination. Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384 [TBL] [Abstract][Full Text] [Related]
18. Effects of a commercial canine gonadotropin releasing hormone vaccine on estrus suppression and estrous behavior in mares. Donovan CE; Hazzard T; Schmidt A; LeMieux J; Hathaway F; Kutzler MA Anim Reprod Sci; 2013 Nov; 142(1-2):42-7. PubMed ID: 24083943 [TBL] [Abstract][Full Text] [Related]
19. Behavior of stabled horses provided continuous or intermittent access to drinking water. McDonnell SM; Freeman DA; Cymbaluk NF; Schott HC; Hinchcliff K; Kyle B Am J Vet Res; 1999 Nov; 60(11):1451-6. PubMed ID: 10566826 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]